Clinical Trial Update: Randomized Trial of Adult Participants With Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

This document reports the completion and posting of results for a Phase 3 randomized trial in adults with Generalized Anxiety Disorder. The sponsor is Biohaven …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Snippet

Sponsor: Biohaven Pharmaceuticals, Inc. | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: COMPLETED | Results posted: 2022-12-28